U Joins National Partnership Aimed at Expanding Biopharmaceutical Workforce and Industry

Jan. 25, 2017
The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.
NIIMBL was announced by Secretary Pritzker in December 2016.
"This partnership will open doors to creating and supporting local biotechnology-related businesses," says Vadim J. Gurvich, Ph.D., M.B.A., Associate Director of the Institute for Therapeutics Discovery and Development within the College of Pharmacy.
Gurvich and six other researchers from the College of Science and Engineering, College of Pharmacy, College of Biological Sciences and Medical School will provide leadership for the University's participation within the partnership.
"This could also open doors to new research collaborations for University of Minnesota faculty," Gurvich said. "Working with local companies, we can make a lasting impact right here in our state, to improve health and find new treatments for diseases like cancer and diabetes."

Read More Here: Health Talk